Dictionaries Armenian-English English-Armenian MeSH Feedback
UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
C C- C1 C3 C5 C6 C7 CA CB CC CD CE CF CG CH CI CJ CK CL CM CN CO CP CQ CR CS CT CU CV CW CX CY CZ
CY CY CYA CYB CYC CYE CYF CYK CYL CYM CYP CYS CYT
selected terms: 496
 << Prev ▫ 1 ▫ 2 ▫ 3 ▫ 4 ▫ 5 ▫ Next >>
 page 2 of 5

101. Cyclophosphamide/Dexamethasone/Doxorubicin/Rituximab/Vincristine
(UMLS (NCI) C1134697) =Therapeutic or Preventive Procedure ;
151. Cyclosporine/Dactinomycin/Vincristine
(UMLS (NCI) C0281292) =Therapeutic or Preventive Procedure
102. Cyclophosphamide/Dexamethasone/Etoposide/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine
(UMLS (NCI) C1134461) =Therapeutic or Preventive Procedure
152. Cyclosporine/Dexamethasone/Doxorubicin/Vincristine
(UMLS (NCI) C0280977) =Therapeutic or Preventive Procedure
103. Cyclophosphamide/Dexamethasone/Mitoxantrone
(UMLS (NCI) C0879544) =Therapeutic or Preventive Procedure ;
153. Cyclosporine/Dexamethasone/Vinblastine
(UMLS (NCI) C0281532) =Therapeutic or Preventive Procedure
104. Cyclophosphamide/Dexrazoxane/Doxorubicin
(UMLS (NCI) C0935845) =Therapeutic or Preventive Procedure
154. Cyclosporine/Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Quinidine/Tamoxifen
(UMLS (NCI) C0281008) =Therapeutic or Preventive Procedure
105. Cyclophosphamide/Dexrazoxane/Doxorubicin/Oblimersen
(UMLS (NCI) C1134674) =Therapeutic or Preventive Procedure
155. Cyclosporine/Etoposide/Mitoxantrone
(UMLS (NCI) C0281279) =Therapeutic or Preventive Procedure
106. Cyclophosphamide/Docetaxel
(UMLS (NCI) C0935668) Docetaxel/Cyclophosphamide;
=Therapeutic or Preventive Procedure
156. Cyclosporine/Etoposide/Vincristine
(UMLS (NCI) C0796412) CYSP/VCR/VP-16 =Therapeutic or Preventive Procedure
107. Cyclophosphamide/Doxorubicin/Epratuzumab/Prednisone/Rituximab/Vincristine
(UMLS (NCI) C1327943) =Therapeutic or Preventive Procedure; ;
157. Cyclosporine/Filgrastim/Methylprednisolone/Monoclonal Antibody Okt3
(UMLS (NCI) C0879520) =Therapeutic or Preventive Procedure ;
108. Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Rituximab/Vincristine
(UMLS (NCI) C1327899) =Therapeutic or Preventive Procedure ;
158. Cyclosporine/Hydroxychloroquine/Prednisone
(UMLS (NCI) C1134592) =Therapeutic or Preventive Procedure ;
109. Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Vincristine
(UMLS (NCI) C0879288) =Therapeutic or Preventive Procedure
159. Cyclosporine/Interferon Alfa/Sargramostim
(UMLS (NCI) C0796608) CYSP/GM-CSF/IFN-A =Therapeutic or Preventive Procedure
110. Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Rituximab/Vincristine
(UMLS (NCI) C0879421) =Therapeutic or Preventive Procedure
160. Cyclosporine/Interferon Gamma
(UMLS (NCI) C0280843) =Therapeutic or Preventive Procedure
111. Cyclophosphamide/Doxorubicin/Etoposide/Rituximab/Vincristine
(UMLS (NCI) C0935756) =Therapeutic or Preventive Procedure
161. Cyclosporine/Interferon Gamma/Interleukin-2
(UMLS (NCI) C0338356) =Therapeutic or Preventive Procedure ;
112. Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Rituximab/Vincristine
(UMLS (NCI) C1134550) =Therapeutic or Preventive Procedure ;
162. Cyclosporine/Interleukin-2/Methylprednisolone
(UMLS (NCI) C0281366) =Therapeutic or Preventive Procedure
113. Cyclophosphamide/Doxorubicin/Iodine I 131 Tositumomab/Prednisone/Vincristine
(UMLS (NCI) C0935736) =Therapeutic or Preventive Procedure
163. Cyclosporine/Irinotecan
(UMLS (NCI) C0796686) =Therapeutic or Preventive Procedure
114. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Rituximab/Vincristine
(UMLS (NCI) C1327931) =Therapeutic or Preventive Procedure; ;
164. Cyclosporine/Irinotecan/Phenobarbital
(UMLS (NCI) C0879312) =Therapeutic or Preventive Procedure
115. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Vincristine
(UMLS (NCI) C1327930) =Therapeutic or Preventive Procedure; ;
165. Cyclosporine/Methotrexate
(UMLS (NCI) C0281560) =Therapeutic or Preventive Procedure ;
116. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Rituximab/Vincristine
(UMLS (NCI) C0935895) =Therapeutic or Preventive Procedure
166. Cyclosporine/Methotrexate/Sirolimus
(UMLS (NCI) C0392980) =Therapeutic or Preventive Procedure
117. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Vincristine
(UMLS (NCI) C0935894) =Therapeutic or Preventive Procedure
167. Cyclosporine/Methylprednisolone
(UMLS (NCI) C0338242) =Therapeutic or Preventive Procedure
118. Cyclophosphamide/Doxorubicin/Oblimersen/Prednisone/Rituximab/Vincristine
(UMLS (NCI) C1328045) =Therapeutic or Preventive Procedure ;
168. Cyclosporine/Methylprednisolone/Mycophenolate Mofetil
(UMLS (NCI) C0935759) =Therapeutic or Preventive Procedure
119. Cyclophosphamide/Doxorubicin/Pegfilgrastim
(UMLS (NCI) C1328069) =Therapeutic or Preventive Procedure; ;
169. Cyclosporine/Methylprednisolone/Prednisone
(UMLS (NCI) C0338362) =Therapeutic or Preventive Procedure ;
120. Cyclophosphamide/Doxorubicin/Prednisolone/Rituximab/Vincristine
(UMLS (NCI) C1328000) =Therapeutic or Preventive Procedure ;
170. Cyclosporine/Mycophenolate Mofetil
(UMLS (NCI) C0677809) =Therapeutic or Preventive Procedure
121. Cyclophosphamide/Doxorubicin/Tipifarnib
(UMLS (NCI) C1327808) =Therapeutic or Preventive Procedure ;
171. Cyclosporine/Paclitaxel
(UMLS (NCI) C0281325) =Therapeutic or Preventive Procedure
122. Cyclophosphamide/Doxorubicin/Tirapazamine
(UMLS (NCI) C1134499) =Therapeutic or Preventive Procedure
172. Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody Lym-1
(UMLS (NCI) C0935749) =Therapeutic or Preventive Procedure
123. Cyclophosphamide/Epirubicin/Fluorouracil/Methotrexate
(UMLS (NCI) C0796647) =Therapeutic or Preventive Procedure
173. Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody M170
(UMLS (NCI) C0935748) =Therapeutic or Preventive Procedure
124. Cyclophosphamide/Epirubicin/Gemcitabine/Paclitaxel
(UMLS (NCI) C1134683) =Therapeutic or Preventive Procedure
174. Cyclosporine/Prednisone
(UMLS (NCI) C0338291) =Therapeutic or Preventive Procedure
125. Cyclophosphamide/Epirubicin/Paclitaxel
(UMLS (NCI) C1134684) =Therapeutic or Preventive Procedure
175. Cyclosporine/Sirolimus
(UMLS (NCI) C1328157) =Therapeutic or Preventive Procedure; ;
126. Cyclophosphamide/Etoposide/Imatinib Mesylate
(UMLS (NCI) C1327818) =Therapeutic or Preventive Procedure ;
176. Cyclosporine/Tamoxifen/Vinblastine
(UMLS (NCI) C0281235) =Therapeutic or Preventive Procedure ;
127. Cyclophosphamide/Etoposide/Imatinib Mesylate/Leucovorin Calcium/Methotrexate
(UMLS (NCI) C1327868) =Therapeutic or Preventive Procedure ;
177. Cyclosporine/Vinblastine
(UMLS (NCI) C0281316) =Therapeutic or Preventive Procedure ;
128. Cyclophosphamide/Etoposide/Leucovorin Calcium/Methotrexate
(UMLS (NCI) C1327867) =Therapeutic or Preventive Procedure
178. Cyclosporine/Yttrium Y 90 Monoclonal Antibody Lym-1
(UMLS (NCI) C0935750) =Therapeutic or Preventive Procedure
129. Cyclophosphamide/Etoposide/Prednisone
(UMLS (NCI) C1327752) =Therapeutic or Preventive Procedure ;
179. Cyclosporine/Yttrium Y 90 Monoclonal Antibody M170
(UMLS (NCI) C0935747) =Therapeutic or Preventive Procedure
130. Cyclophosphamide/Filgrastim/Rituximab
(UMLS (NCI) C1328070) =Therapeutic or Preventive Procedure; ;
180. CYCLOTHIAZIDE
(UMLS (NCI) C0056831) =Organic Chemical; Pharmacologic Substance =benzothiadiazine;
[CV701] THIAZIDES/RELATED DIURETICS
131. Cyclophosphamide/Fludarabine/Melphalan
(UMLS (NCI) C1327796) =Therapeutic or Preventive Procedure ;
181. cyclotron
[Devices for accelerating charged particles in a spiral path by a constant-frequency alternating electric field. This electric field is synchronized with the movement of the particles in a constant magnetic field. ( MSH )] (UMLS (CSP) C0010600) =Manufactured Object ;
132. Cyclophosphamide/Fludarabine/Oblimersen
(UMLS (NCI) C1134472) =Therapeutic or Preventive Procedure
182. CYCLOTROPIA
[ ] (UMLS (ICD9CM) C0152209) =Disease or Syndrome ;
133. Cyclophosphamide/Fludarabine/Rituximab
(UMLS (NCI) C1327865) =Therapeutic or Preventive Procedure
183. CYCRIMINE
(UMLS (NCI) C0056835) =Organic Chemical; Pharmacologic Substance
134. Cyclophosphamide/Fluorouracil/Methotrexate/Trastuzumab
(UMLS (NCI) C1134648) =Therapeutic or Preventive Procedure
184. Cycrin
(UMLS (NCI) C0699705) =Steroid; Pharmacologic Substance ;
135. Cyclophosphamide/Methotrexate/Pegaspargase/Vincristine
(UMLS (NCI) C0879562) =Therapeutic or Preventive Procedure
185. CYFRA 21-1
[A fragment of cytokeratin 19. A tumor marker. Reported to be a sensitive serum marker of recurrent breast cancer. May also be a good prognostic marker, with patients with high serum levels of the marker having shorter disease-free survival. (from Cancer 2000;89:1285-1290 via Medscape) ( NCI )] (UMLS (NCI) C0530993) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
136. Cyclophosphamide/Methylprednisolone/Rasburicase/Vincristine
(UMLS (NCI) C1327934) =Therapeutic or Preventive Procedure; ;
186. Cyklokapron
(UMLS (NCI) C0591311) =Organic Chemical; Pharmacologic Substance ;
137. Cyclophosphamide/Methylprednisolone/Rituximab
(UMLS (NCI) C1328013) =Therapeutic or Preventive Procedure ;
187. CYL
[A container designed specifically to hold gases. ( NCI )] (UMLS (NCI) C0181797) =Medical Device
138. Cyclophosphamide/Oblimersen
(UMLS (NCI) C1327956) =Therapeutic or Preventive Procedure; ;
188. Cylinder
[A surface formed by circles of a given radius that are contained in a plane perpendicular to a given axis, whose centers align on the axis. ( NCI )] (UMLS (NCI) C0946010) Cylindrical =Organism Attribute ;
139. Cyclophosphamide/Pentostatin/Rituximab
(UMLS (NCI) C1134660) =Therapeutic or Preventive Procedure
189. Cylindroma
[A benign sweat gland neoplasm usually occurring in the scalp or the face. It may present as solitary or multiple papular or nodular lesions. It may be a sporadic lesion or part of Brooke-Spiegler syndrome. It arises from the dermis and has a multinodular, circumscribed appearance. The nodules contain basaloid cells with small, dark nuclei. Complete excision is usually curative. ( NCI )] (UMLS (NCI) C1305968) Cylindroma of Skin;
Cylindroma of the Skin;
Dermal Cylindroma =Neoplastic Process
140. Cyclophosphamide/Prednisone/Rasburicase/Vincristine
(UMLS (NCI) C1327933) =Therapeutic or Preventive Procedure; ;
190. Cylindromatous Pattern
(UMLS (NCI) C1333184) =Finding ;
141. Cyclophosphamide/Prednisone/Rituximab
(UMLS (NCI) C1328014) =Therapeutic or Preventive Procedure ;
191. Cymba Conchae
(UMLS (NCI) C0229317) =Body Part, Organ, or Organ Component
142. CYCLOPHOTOCOAGULATION
[ ] (UMLS (ICD9CM) C0395490) =Therapeutic or Preventive Procedure
192. CYP
[hemeproteins whose characteristic mode of action involves transfer of reducing equivalents which are associated with a reversible change in oxidation state of the prosthetic group; the various cytochrome subclasses are organized by the type of heme and by the wavelength range of their reduced alpha-absorption bands. ( CSP )] (UMLS (NCI) C0010798) =Amino Acid, Peptide, or Protein; Biologically Active Substance =heme protein;
=cytochrome b;
cytochrome c;
CYP (cytochrome P450);
cytochrome b2
143. cycloplegic
[ ] (UMLS (CSP) C0010586) =Pharmacologic Substance ;
193. CYP (cytochrome P450)
[superfamily of closely related heme enzymes found throughout the phylogenetic spectrum; they catalyze the insertion of an atom of oxygen into substrates; in animals, these P-450 enzymes are involved in biosynthesis of steroids, fatty acids, and bile acids and also in metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs. ( CSP )] (UMLS (CSP) C0010762) =Amino Acid, Peptide, or Protein; Enzyme =CYP;
Enzymes, Coenzymes, and Enzyme Inhibitors =aryl 4 monooxygenase;
CYP3A;
CPB6;
CYP 2C9;
CYP 2C;
CYP 2C19;
CYP 2C18;
CYP 3A3/4;
CYP 3A5-7;
CYP 2C8
144. cyclopropane
[C3H6; a flammable moderately toxic narcotic colorless gas used in organic synthesis and as an anesthetic. ( CSP )] (UMLS (CSP) C0010587) =Organic Chemical; Pharmacologic Substance =cyclic compound;
194. CYP11A1
[This gene is involved in steroid metabolism. ( NCI )] (UMLS (NCI) C1413855) CYP11A1 Gene;
Cytochrome P450, Family 11, Subfamily A, Polypeptide 1 Gene =Gene or Genome
145. Cyclopropaneacetic Acid, 1-((((1R)-1-(3-((1E)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, Monosodium Salt
[The monosodium salt of montelukast, a selective and orally active leukotriene receptor antagonist with anti-inflammatory and bronchodilator activity. Montelukast sodium selectively and competitively blocks the cysteinyl leukotriene 1 (CysLT1) receptor, thereby preventing leukotriene D4 from binding to its receptor. This prevents leukotriene-mediated activities, including enhanced migration of eosinophils and neutrophils, increased adhesion of leukocytes, increased monocyte and neutrophil aggregation, increased airway edema, increased capillary permeability and bronchoconstriction. ( NCI )] (UMLS (NCI) C0380447) =Organic Chemical; Pharmacologic Substance ;
=MONTELUKAST;
=MONTELUKAST SODIUM 10 MG;
MONTELUKAST SODIUM 5 MG;
MONTELUKAST SODIUM 4 MG;
195. CYP11B1
[Encoded by human CYP11B1 Gene (Cytochrome P450 Family), 503-aa 58-kDa (precursor) Cytochrome P450 CYP11B1 is a mitochondrial inner membrane P450 heme-thiolate monooxygenase expressed in adrenal cortex with steroid 11-beta-hydroxylase activity and involved in conversion of progesterone to cortisol. The 18 or 19-hydroxylation of steroids and aromatization of androstendione to estrone have also been ascribed to CYP11B1. CYP11B1 defects cause adrenal hyperplasia type IV (AH-IV). CYP11B1/CYP11B2 gene fusion causes glucocorticoid-remediable aldosteronism (GRA). P450 enzymes catalyze reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. (NCI) ( NCI )] (UMLS (NCI) C0038296) =Amino Acid, Peptide, or Protein; Enzyme =Oxygenase;
146. cyclopropene
[ ] (UMLS (CSP) C0056811) =Organic Chemical ;
196. CYP11B1
[This gene plays a role in the metabolism of glucucorticoids. ( NCI )] (UMLS (NCI) C1413856) CYP11B1 Gene;
Cytochrome P450, Family 11, Subfamily B, Polypeptide 1 Gene =Gene or Genome
147. cyclosarin
[ ] (UMLS (CSP) C0164843) =Organic Chemical; Hazardous or Poisonous Substance ;
197. CYP11B2
[This gene is involved in mineralocorticoid metabolism. ( NCI )] (UMLS (NCI) C1413857) CYP11B2 Gene;
Cytochrome P450, Family 11, Subfamily B, Polypeptide 2 Gene =Gene or Genome
148. cyclosis
[ ] (UMLS (CSP) C0599227) =Cell Function
198. CYP17A1
[Encoded by human CYP17A1 Gene (Cytochrome P450 Family), 508-aa 57-kDa Cytochrome P450 XVIIA1 is a cAMP-regulated endoplasmic reticulum P450 heme-thiolate monooxygenase with 17alpha-hydroxylase and 17,20-lyase activity and a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Involved in fetal and adult sexual development, CYP17A1 converts pregnenolone and progesterone to their 17-alpha-hydroxylated products and subsequently to dehydroepiandrosterone (DHEA) and androstenedione. CYP17A1 mutations are associated with steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia type V (AH-V). P450 enzymes catalyze reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. (NCI) ( NCI )] (UMLS (NCI) C0038302) =Amino Acid, Peptide, or Protein; Enzyme =Oxygenase;
149. Cyclospora
[genus of coccidian parasites in the family Eimeriidae; Cyclospora cayetanensis is pathogenic in humans, probably transmitted via the fecal-oral route, and causes nausea and diarrhea. ( CSP )] (UMLS (CSP) C0522435) =Invertebrate =Coccidia;
199. CYP17A1
[This gene plays a role in the metabolism of estrogen and glucocorticoids. It is also involved in sexual maturation. ( NCI )] (UMLS (NCI) C1413858) CYP17A1 Gene;
Cytochrome P450, Family 17, Subfamily A, Polypeptide 1 Gene =Gene or Genome
150. CYCLOSPORIASIS
[Infection with parasitic protozoa of the genus CYCLOSPORA. It is distributed globally and causes a diarrheal illness. Transmission is waterborne. ( MSH )] (UMLS (ICD9CM) C0343398) =Disease or Syndrome =coccidiosis;
200. CYP19A1
[This gene is involved in development and estrogen metabolism. ( NCI )] (UMLS (NCI) C1366496) CYP19A1 Gene;
Cytochrome P450, Family 19, Subfamily A, Polypeptide 1 Gene =Gene or Genome

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM